CDXS - Pendapatan operasional sadurunge ngurangi amortisasi codexis.com
Codexis, Inc. (CDXS) EBITDA dynamics are supported by biocatalyst sales and ECO Synthesis licenses. Growth is driven by the creation of clean catalysts for the industry and synergy with pharma behemoths via CodeEvolver. The 0.00 metric indicates the current level of operational efficiency, confirming the business's strength, although the upward trend may signal a risk of overvalued shares.
Ringkesan rincian data analitis Codexis (CDXS)
- rega saham lan prakiraan rega para ahli:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Koefisien Total Utang marang Modal Codexis, Inc.|CDXS - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Codexis Inc|CDXS - Gunggung utang perusahaan|Utang marang nilai buku Codexis, Inc.|CDXS - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak Codexis, Inc.|Indikator likuiditas cepet codexis.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CDXS - Bathi resik|Prakiraan bathi resik Codexis, Inc.|CDXS - Koefisien rega marang bathi|Rasio rega marang bathi mangsa ngarep Codexis Inc|CDXS - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Codexis, Inc.|CDXS - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Codexis, Inc.|CDXS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan codexis.com|CDXS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Codexis, Inc.
Ringkesan analitik perusahaan:CDXS - Codexis, Inc.
This metric reflects net cash flow from operating activities before depreciation, allowing for an assessment of the ability of Codexis, Inc. (CDXS) to convert unique patented enzymes into actual revenue. By analyzing operating profit trends, an investor can see how the company's pricing power in bioengineering offsets inflationary costs, transforming technological superiority into a sustainable financial base and operational flexibility.
Analisis pesaing Codexis, Inc.
TEM: Bathi operasional sadurunge amortisasi|Qiagen N.V. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi ionispharma.com IONS|Repligen (RGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RNA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi CRSP|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RARE|Pendapatan operasional sadurunge ngurangi amortisasi beamtx.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|TWST: Bathi operasional sadurunge amortisasi|10x Genomics Corp - Bathi operasional EBITDA|Intellia Corp (NTLA) - Bathi operasional sadurunge ngurangi amortisasi|STOK (Stoke Therapeutics) - Bathi operasional sadurunge ngurangi amortisasi|BLFS - Pendapatan operasional sadurunge ngurangi amortisasi|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Maze Therapeutics, Inc. (MAZE)|Bathi operasional EBITDA SION|Prime Medicine Bio - Bathi operasional sadurunge amortisasi|Taysha Gene Therapies - Bathi operasional sadurunge ngurangi amortisasi|QURE: Bathi operasional sadurunge amortisasi|MGTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi REGENXBIO Inc RGNX|SLDB: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi OCGN|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pacific Biosciences|Bathi operasional sadurunge amortisasi BNTC (benitec.com)|Bathi operasional EBITDA DSGN|Bathi operasional EBITDA Rocket Pharma (RCKT)|Bathi operasional EBITDA FDMT (4D Molecular Therapeutics Inc)|LXEO - Bathi operasional sadurunge ngurangi amortisasi|KRRO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi editasmedicine.com|SLN: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi PRQR|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Nautilus Biotechnology Inc NAUT|Bathi operasional sadurunge ngurangi amortisasi MGX (Metagenomi, Inc.)|precisionbiosciences.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA GBIO (Generation Bio)|Pendapatan operasional sadurunge ngurangi amortisasi Boundless Bio Inc. (BOLD)|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Imunon, Inc. IMNN|PHIO (phiopharma.com) - Bathi operasional sadurunge ngurangi amortisasi|Mustang Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RNAZ (TransCode Therapeutics Inc.) - Bathi operasional EBITDA|Bionano (BNGO) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Applied DNA (APDN)|bluebird bio, Inc - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|OMGA - Bathi operasional sadurunge ngurangi amortisasi|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Regulus Therapeutics, Inc. RGLS|SYRS: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Telesis Bio, Inc|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi UBX (unitybiotechnology.com)
